Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196.SS) SHH
22.22
-0.5(-2.20%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
22.22
-0.5(-2.20%)
Currency In CNY
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
40557
First IPO Date
August 07, 1998
| Name | Title | Pay | Year Born |
| Wenjie Zhang | Co-President & Co-CEO of Innovative Medicines Division | 0 | 1967 |
| Jing Li | Co-President and Chief Executive Officer of Established Medicines Manufacturing & Supply Division | 0 | 1972 |
| Yi Liu | President, CEO, Co-Chair of the Innov Drugs, Chair, CEO of the Diag & Therap Tech & Exec Director | 0 | 1975 |
| Wang Xingli | Co-President & CEO of the Innovative Drugs Business Unit | 0 | 1962 |
| Deyong Wen | Executive Vice Chairman | 9.14M | 1971 |
| Yuqing Chen | Executive Chairman | 12.14M | 1975 |
| Xiaohui Guan | Executive Co-Chairman | 15.25M | 1971 |
| Kexin Wang | Executive Director | 0 | 1965 |
| Donghua Wang | Senior Vice President | 0 | 1969 |
| Zhanyu Chen | Senior Vice President & Chief Financial Officer | 0 | 1972 |
| Rongli Feng | Executive President & Chief Human Resources Officer | 0 | 1975 |
| Yue Zhu | Vice President & GM of Legal Department | 0 | 1977 |
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. develops, manufactures, and sells pharmaceutical products in Mainland China and internationally. It operates in five segments: Pharmaceutical Manufacturing, Medical Devices and Medical Diagnosis, Healthcare Service, Pharmaceutical Distribution and Retail, Other Business segments. The company offers pharmaceutical products in the areas of tumor, immune modulation, metabolism, alimentary and central nervous system. It also provides medical devices and diagnostic products. In addition, the company offers health care and hospital management services. Further, it engages in retail and wholesale distribution of medicines. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.